SCHEMBL17992069

SCHEMBL17992069

CN(C)c1ccc(CNC2=Nc3ccccc3NC23CCOCC3)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 4/20 0.39
▸ NPC1 O15118 3/20 0.39
▸ RAB9A P51151 3/20 0.39
▸ ELANE P08246 1/20 0.38
▸ L3MBTL1 Q9Y468 3/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ MAPK1 P28482 6/20 0.35
▸ LMNA P02545 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ MAPT P10636 7/20 0.34
▸ TSHR P16473 1/20 0.34
▸ TDP1 Q9NUW8 4/20 0.34
▸ ALDH1A1 P00352 9/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ MITF O75030 1/20 0.33
▸ KDM4E B2RXH2 4/20 0.33
▸ CYP1A2 P05177 4/20 0.33
▸ TP53 P04637 3/20 0.33
▸ CYP3A4 P08684 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17992098 0.89 LMNA (0.31) LMNATSHRALDH1A1
SCHEMBL17992118 0.89 GAA (0.41) GAANPC1RAB9AELANEL3MBTL1
SCHEMBL17757018 0.89 LMNA (0.39) GAANPC1RAB9AL3MBTL1LMNA
SCHEMBL17992051 0.89 EGFR (0.34) NPC1RAB9AL3MBTL1MAPK1
SCHEMBL17992055 0.88 GAA (0.40) GAANPC1RAB9AELANEL3MBTL1
SCHEMBL17757836 0.88 HTT (0.38) GAAKMT2ALMNAHTTTSHR
SCHEMBL17992086 0.87 GAA (0.39) GAANPC1RAB9AELANEL3MBTL1
SCHEMBL17757540 0.86 GAA (0.34) GAANPC1RAB9AL3MBTL1MAPK1
SCHEMBL17757331 0.86 MAPT (0.33) L3MBTL1MEN1KMT2ALMNAHTT
SCHEMBL17757328 0.86 POLB (0.39) GAANPC1RAB9AL3MBTL1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3021847-B1 SPIROQUINOXALINE DERIVATIVES AS INHIBITORS OF NON-APOPTOTIC REGULATED CELL-DEATH HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM GESUNDHEIT & UMWELT GMBH (DE) 2023-06-07 — — EP disclosed
US-RE48992-E1 Spiroquinoxaline derivatives as inhibitors of non-apoptotic regulated cell-death HELMHOLTZ ZENTRUM MÜNCHEN-DEUTSCHES FORSCHUNGSZENTRUM FÜR GESUNDHEIT UND UMWELT (GMBH) (DE) 2022-03-29 — — US disclosed
US-10647687-B2 Spiropyrazine derivatives as inhibitors of non-apoptotic regulated cell-death HELMHOLTZ ZENTRUM MÜNCHEN DEUTSCHES FORSCHUNGSZENTRUM FÜR GESUNDHEIT UND UMWELT (GMBH) (DE) 2020-05-12 — — US disclosed
US-9802956-B2 Spiroquinoxaline derivatives as inhibitors of non-apoptotic regulated cell-death HELMHOLTZ ZENTRUM MUNCHEN-DEUTSCHES FORSCHUNGSZENTRUM FUR GESUNDHEIT UND UMWELT (GMBH) (DE) 2017-10-31 — — US disclosed
US-20160222025-A1 SPIROQUINOXALINE DERIVATIVES AS INHIBITORS OF NON-APOPTOTIC REGULATED CELL-DEATH HELMHOLTZ ZENTRUM MUNCHEN (DE) 2016-08-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10647687-B2 Spiropyrazine derivatives as inhibitors of non-apoptotic regulated cell-death AIFM2, BAD, AIFM1 GAA 2647/4885NPC1 1194/4885RAB9A 4069/4885
US-20160222025-A1 SPIROQUINOXALINE DERIVATIVES AS INHIBITORS OF NON-APOPTOTIC REGULATED CELL-DEATH AIFM2, BAD, AIFM1 GAA 1605/4885NPC1 932/4885RAB9A 2221/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback